Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
434.00    -11.00 (-2.47%)
Bid:
434.00
Ask:
445.00
Spread: 11.00 (2.535%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

31 Jul 2014 07:00

RNS Number : 7902N
Creston PLC
31 July 2014
 



 

31 July 2014

 

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the international marketing communications group, today announces its interim management statement for the period 1 April 2014 to date.

 

In the three months to 30 June 2014 ('the Period'), there was an increase of 3 per cent in Group revenue compared to the prior year period, and like-for-like1 revenue grew by 2 per cent. This has been driven primarily by the impact of prior year client wins and the growth of our international work for existing clients.

 

Our new business performance in the first quarter of this financial year has been good with activity in line with the same prior year period and has added a breadth of new clients and digital assignments to the Group. Major wins during the Period include Activision, to handle its pan-European social media content; the growth of our events programme for Bentley from UK to pan-Europe; a new HIV prevention client at CDC; an internal referral win from Danone; McCain, to handle the digital work across all of its UK brands; the Right to Buy digital contract through the Crown Commercial Service; Sony Mobile, to manage global email production; and our first global digital win for a Unilever brand.

 

Both our recent acquisitions, healthcare PR agency Liberation and neuroscience specialist, Walnut Group, whilst not material, are performing well. Liberation was named Small Consultancy of the Year at the recent Communiqué awards for the Healthcare industry, while Walnut Group has further strengthened our Insight offering which is being increasingly leveraged across the Group as a point of differentiation to create new client opportunities.

 

The Group is on track with its previously announced plans to reposition Creston as an agency group under the unifying Unlimited brand in the second half of FY15; and effective from 1 July 2014 Kathryn Herrick joined the Board and Group as Chief Financial Officer.

 

While it is still early in the financial year, the Board confirms that current trading is in line with its expectations for the full year.

 

-ends-

 

For further information please contact:

 

Creston plc

+44 (0)20 7930 9757

Barrie Brien, Group Chief Executive

Kathryn Herrick, Chief Financial Officer

Bell Pottinger

+44 (0)20 7861 2840 

Elly Williamson / Malika Shermatova

 

___________________

1 Like-for-like excludes the results from any acquisitions made during the current year, it compares current year performance to the prior year, adjusting the current year to only include the results of prior year acquisitions for the commensurate period of ownership.

 

 

About Creston plc

Creston plc (LSE: CRE) is an international marketing communications group that leverages the strength of its agencies' collective expertise and knowledge across insight, technology and creativity to drive transformational growth for its clients through thinking and ideas that connect brands to customers. The Group delivers a range of marketing services, including advertising, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. www.creston.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASXEDDNLEFF
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.